Mounjaro 5 mg (Tirzepatide) Injection
Mounjaro 5 mg (tirzepatide) is a prescription medicine used for approved medical indications, including the treatment of type 2 diabetes and, in applicable markets, weight management. Mounjaro contains tirzepatide, an active substance that acts on GIP and GLP-1 receptors.
If you are looking for Mounjaro 5 mg, view our Mounjaro products or speak with a qualified healthcare professional to determine whether this medicine is appropriate for you.
Prescription medicine: Mounjaro should only be supplied and used in accordance with the prescription and regulatory requirements applicable in your country.
Mounjaro 5 mg Overview
Mounjaro contains the active ingredient tirzepatide and is supplied in prefilled injection devices. Product presentations can differ between countries.
For customers looking for related products, see our Tirzepatide products and prescription medicines.
In the European Union, Mounjaro is authorised for specific indications involving type 2 diabetes and weight management in eligible adults. For the latest regulatory information, see the European Medicines Agency Mounjaro information.
What Is Mounjaro (Tirzepatide)?
Mounjaro is a medicine containing tirzepatide. Tirzepatide acts on GIP and GLP-1 receptors. These pathways are involved in glucose regulation and appetite.
Mounjaro is used together with appropriate diet and physical activity according to its approved indication and the advice of a healthcare professional.
You can learn more about related treatment options in our diabetes medicines and weight management medicines categories.
Mounjaro 5 mg Uses
The approved uses of Mounjaro vary according to the country and regulatory authority.
In the European Union, Mounjaro is authorised for adults with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise. It is also authorised for weight management, including weight loss and weight maintenance, in eligible adults with obesity or overweight accompanied by specified weight-related health conditions.
For current EU regulatory information, visit the European Medicines Agency Mounjaro page.
For UK-specific patient information, see the Mounjaro 5 mg KwikPen Patient Information Leaflet.
Mounjaro 5 mg Injection
Mounjaro is administered as a subcutaneous injection according to the instructions provided with the prescribed product.
The medicine is generally administered once weekly. Patients should follow the dosing instructions provided by their prescriber and the official product information supplied with their medicine.
For more information, see our Mounjaro dosage guide.
Do not change your prescribed dose or injection schedule without consulting your doctor, pharmacist or other qualified healthcare professional.
Mounjaro 5 mg Storage
Mounjaro requires appropriate storage conditions.
The exact storage requirements depend on the product presentation and market. Always check the packaging and official patient information supplied with your medicine.
If you purchase or receive a refrigerated medicine, see our guide to storing refrigerated medicines for general information.
For UK patients, the official Mounjaro 5 mg KwikPen patient leaflet provides product-specific storage instructions.
Mounjaro 5 mg Prescription Information
Mounjaro is a prescription medicine. It should be supplied through an appropriately regulated pharmacy or healthcare provider and used under appropriate medical supervision.
Before treatment, a healthcare professional should determine whether Mounjaro is suitable for you based on your medical history, current medicines and the approved indication.
If you have questions about prescription requirements or treatment suitability, contact our pharmacist.
Mounjaro 5 mg FAQs
What is Mounjaro 5 mg?
Mounjaro 5 mg is a prescription strength containing 5 mg of the active ingredient tirzepatide in the relevant dose presentation.
Is Mounjaro the same as tirzepatide?
Mounjaro is the brand name, while tirzepatide is the active ingredient.
Is Mounjaro a GLP-1 medicine?
Tirzepatide acts on both GIP and GLP-1 receptors. It is therefore different from medicines that act only on the GLP-1 receptor.
How often is Mounjaro administered?
Mounjaro is generally administered once weekly when prescribed for an approved indication. Follow the exact instructions provided by your healthcare professional and the product information.
Does Mounjaro need refrigeration?
Mounjaro has specific storage requirements, which can vary according to the product presentation. Follow the storage instructions supplied with your medicine.
Can I use Mounjaro without a prescription?
Mounjaro is a prescription medicine. It should only be obtained and used in accordance with applicable prescribing and pharmacy regulations.
Is Mounjaro available in the UK and Europe?
Mounjaro is authorised in the EU, while UK product information is available through the electronic Medicines Compendium. However, product presentations, indications and regulatory requirements can differ between countries.
See the UK Mounjaro medicine information or the European Medicines Agency Mounjaro information.
Important Information
This product information is provided for general educational purposes and does not replace advice from a doctor or pharmacist.
Always use Mounjaro exactly as prescribed and read the official patient information supplied with your medicine.
Product presentation, approved indications, packaging, storage conditions and availability can differ between the UK, United States, European Union and other markets. Verify the exact product supplied against the applicable official product information.
Reviews
There are no reviews yet.